N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart Failure

Interaction Between NFκB and NFAT Coordinates Cardiac Hypertrophy and Pathological Remodeling

(2012) Qinghang Liu et al.   CIRCULATION RESEARCH

A Novel Intracellular Isoform of Matrix Metalloproteinase-2 Induced by Oxidative Stress Activates Innate Immunity

(2012) David H. Lovett et al.   PLoS One

The Emerging Role of Innate Immunity in the Heart and Vascular System

(2011) Douglas L. Mann   CIRCULATION RESEARCH

Multiple Facets of NF-κB in the Heart

(2011) Joseph W. Gordon et al.   CIRCULATION RESEARCH

Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes

(2011) Elen Rizzi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mechanisms of cytosolic targeting of matrix metalloproteinase-2

(2011) Mohammad A.M. Ali et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Innate immune signaling in cardiac ischemia

(2011) Fatih Arslan et al.   Nature Reviews Cardiology

Innate immunity and remodelling

(2010) Guro Valen   HEART FAILURE REVIEWS

Clinical Significance of Matrix Metalloproteinase (MMP)-2 in Patients With Acute Heart Failure

(2010) Akihiro Shirakabe et al.   International Heart Journal

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

(2008) Rajeev Mahimkar et al.   CARDIOVASCULAR PATHOLOGY

Ultrastructural definition of apoptosis in heart failure

(2008) Eloisa Arbustini et al.   HEART FAILURE REVIEWS

Expression of EGFP and NPTII Protein Is Not Associated with Organ Abnormalities in Deceased Transgenic Cloned Cattle

(2008) Yan Liu et al.   Cloning Stem Cells

Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κB

(2007) Sudhiranjan Gupta et al.   JOURNAL OF MOLECULAR BIOLOGY